Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update Life Science Investing
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights Life Science Investing
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity Life Science Investing
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer Life Science Investing
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights Biotech Investing
Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease Biotech Investing
PharmaTher Establishes PERSONALIZ3D to Commercialize a Personalized Medicine Platform Combining Telehealth and Pharmaceutical 3D Printing Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
